Dongjun Li, Michael Kirberger, Jingjuan Qiao, Zongxiang Gui, Shenghui Xue, Fan Pu, Jie Jiang, Yiting Xu, Shanshan Tan, Mani Salarian, Oluwatosin Ibhagui, Khan Hekmatyar, Jenny J Yang
Cancer and other acute and chronic diseases are results of perturbations of common molecular determinants in key biological and signaling processes. Imaging is critical for characterizing dynamic changes in tumors and metastases, the tumor microenvironment, tumor-stroma interactions, and drug targets, at multiscale levels. Magnetic resonance imaging (MRI) has emerged to be a primary imaging modality for both clinical and preclinical applications due to its advantages over other modalities, including sensitivity to soft tissues, nondepth limitations, and the use of nonionizing radiation...
February 1, 2024: Investigative Radiology